Article

Regulation of Autologous Stem Cell Therapies: Report on Canadian Unsanctioned Businesses

2024-11-28

Abstract excerpt

<title>Abstract</title> <p>Advances in the field of regenerative medicine have allowed for the rapid development of stem cell-based therapies in the hope of treating numerous debilitating diseases. Most of these therapies are not fully ready to be administered to patients, but hundreds of businesses around the world exploit the excitement around stem cells’ therapeutic potential to sell unproven stem cell product...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 02e9d12d-507e-503b-a983-b005f5978509
DOI: 10.21203/rs.3.rs-5364001/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Regulation of Autologous Stem Cell Therapies: Report on Canadian Unsanctioned BusinessesDOI 10.21203/rs.3.rs-5364001/v1Read

Unproven stem cell-based interventions and achieving a compromise policy among the multiple stakeholders.Semantic proximity Read

Ethical and human subject burdens of trials conducted to evaluate biosimilarsSemantic proximity Read

Awareness and perceptions among members of a Japanese cancer patient advocacy group concerning the financial relationships between the pharmaceutical industry and physicians: a mixed-methods analysis of survey dataSemantic proximity Read

§ 1498: A Guide to Government Patent Use, a Path to Licensing and Distributing Generic DrugsSemantic proximity Read

Avoiding the TRIPS Trap: A Path to Domestic Disclosure of Clinical Drug Data Consistent with International NormsSemantic proximity Read

Cross-sectional analysis of Open payments for physicians at designated hemophilia centers in the US (2018-2020)Semantic proximity Read

Intra-operative use of biological products -- Are we aware of their derivatives?Semantic proximity Read

Evaluation of non-research and research industry payments to pediatric hematologist/oncologists in the United States between 2013 and 2021Semantic proximity Read

Animal Rights Activism and the Constitution: Are Ag-Gag Laws Justifiable Limits?Semantic proximity Read

Commercialization, patenting and genomics: researcher perspectivesSemantic proximity Read

Strategic Use of Patent Opposition Safeguard to Improve Equitable Access to Innovative Health Technologies: A Case Study of CAR T-Cell Therapy KymriahSemantic proximity Read

Awareness and perceptions among members of a Japanese cancer patient advocacy group concerning the financial relationships between the pharmaceutical industry and physicians: a mixed-methods analysis of survey dataSemantic proximity Read